• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体泛素受体hRpn13及其相互作用的去泛素化酶Uch37是正常细胞周期进程所必需的。

The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.

作者信息

Randles Leah, Anchoori Ravi K, Roden Richard B S, Walters Kylie J

机构信息

From the Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, NCI, National Institutes of Health, Frederick, Maryland 21702 and.

the Departments of Oncology.

出版信息

J Biol Chem. 2016 Apr 15;291(16):8773-83. doi: 10.1074/jbc.M115.694588. Epub 2016 Feb 23.

DOI:10.1074/jbc.M115.694588
PMID:26907685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4861445/
Abstract

Recently, we reported that bisbenzylidine piperidone RA190 adducts to Cys-88 of the proteasome ubiquitin receptor hRpn13, triggering accumulation of ubiquitinated proteins and endoplasmic reticulum stress-related apoptosis in various cancer cell lines. hRpn13 contains an N-terminal pleckstrin-like receptor for ubiquitin domain that binds ubiquitin and docks it into the proteasome as well as a C-terminal deubiquitinase adaptor (DEUBAD) domain that binds the deubiquitinating enzyme Uch37. Here we report that hRpn13 and Uch37 are required for proper cell cycle progression and that their protein knockdown leads to stalling at G0/G1 Moreover, serum-starved cells display reduced hRpn13 and Uch37 protein levels with hallmarks of G0/G1 stalling and recovery to their steady-state protein levels following release from nutrient deprivation. Interestingly, loss of hRpn13 correlates with a small but statistically significant reduction in Uch37 protein levels, suggesting that hRpn13 interaction may stabilize this deubiquitinating enzyme in human cells. We also find that RA190 treatment leads to a loss of S phase, suggesting a block of DNA replication, and G2 arrest by using fluorescence-activated cell sorting. Uch37 deprivation further indicated a reduction of DNA replication and G0/G1 stalling. Overall, this work implicates hRpn13 and Uch37 in cell cycle progression, providing a rationale for their function in cellular proliferation and for the apoptotic effect of the hRpn13-targeting molecule RA190.

摘要

最近,我们报道双苄叉哌啶酮RA190与蛋白酶体泛素受体hRpn13的Cys-88结合,在多种癌细胞系中引发泛素化蛋白的积累和内质网应激相关的凋亡。hRpn13包含一个用于泛素结构域的N端普列克底物蛋白样受体,该受体结合泛素并将其对接至蛋白酶体,以及一个C端去泛素化酶衔接子(DEUBAD)结构域,该结构域结合去泛素化酶Uch37。在此我们报道hRpn13和Uch37是细胞周期正常进展所必需的,它们的蛋白敲低会导致细胞停滞在G0/G1期。此外,血清饥饿细胞显示hRpn13和Uch37蛋白水平降低,具有G0/G1期停滞的特征,并且在从营养剥夺中释放后恢复到其稳态蛋白水平。有趣的是,hRpn13的缺失与Uch37蛋白水平的小幅但具有统计学意义的降低相关,这表明hRpn13的相互作用可能会在人类细胞中稳定这种去泛素化酶。我们还发现RA190处理会导致S期缺失,提示DNA复制受阻,并通过荧光激活细胞分选导致G2期停滞。Uch37缺失进一步表明DNA复制减少和G0/G1期停滞。总体而言,这项工作表明hRpn13和Uch37参与细胞周期进展,为它们在细胞增殖中的功能以及靶向hRpn13的分子RA190的凋亡作用提供了理论依据。

相似文献

1
The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.蛋白酶体泛素受体hRpn13及其相互作用的去泛素化酶Uch37是正常细胞周期进程所必需的。
J Biol Chem. 2016 Apr 15;291(16):8773-83. doi: 10.1074/jbc.M115.694588. Epub 2016 Feb 23.
2
Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity.失去 hRpn13 Pru 或 UCHL5 对泛素化蛋白的蛋白酶体清除和 RA190 细胞毒性的影响。
Mol Cell Biol. 2020 Aug 28;40(18). doi: 10.1128/MCB.00122-20.
3
Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.Rpn13-Rpn2 复合物的结构为 Rpn13 和 Uch37 作为抗癌靶点提供了线索。
Nat Commun. 2017 Jun 9;8:15540. doi: 10.1038/ncomms15540.
4
A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.一种新型蛋白酶体相互作用蛋白将去泛素化酶UCH37招募至26S蛋白酶体。
EMBO J. 2006 Oct 4;25(19):4524-36. doi: 10.1038/sj.emboj.7601338. Epub 2006 Sep 21.
5
A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells.一种高亲和力的源自hRpn2的肽,可在293T细胞中从蛋白酶体上取代人Rpn13。
PLoS One. 2015 Oct 14;10(10):e0140518. doi: 10.1371/journal.pone.0140518. eCollection 2015.
6
hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.人源Rpn13/ADRM1/GP110是一种新型蛋白酶体亚基,可与去泛素化酶UCH37结合。
EMBO J. 2006 Dec 13;25(24):5742-53. doi: 10.1038/sj.emboj.7601450. Epub 2006 Nov 30.
7
Structure of proteasome ubiquitin receptor hRpn13 and its activation by the scaffolding protein hRpn2.蛋白酶体泛素受体 hRpn13 的结构及其被支架蛋白 hRpn2 激活。
Mol Cell. 2010 May 14;38(3):404-15. doi: 10.1016/j.molcel.2010.04.019.
8
Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.Adrm1介导蛋白酶体招募并激活Uch37去泛素化酶。
Nat Cell Biol. 2006 Sep;8(9):994-1002. doi: 10.1038/ncb1460. Epub 2006 Aug 13.
9
A structure-based designed small molecule depletes hRpn13 and a select group of KEN box proteins.基于结构设计的小分子耗尽 hRpn13 和一组选择的 KEN 盒蛋白。
Nat Commun. 2024 Mar 20;15(1):2485. doi: 10.1038/s41467-024-46644-7.
10
hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected].hRpn13,一种新鉴定的 19S 颗粒组分,调节人成骨样细胞系 MG63 的增殖、分化和功能。[已更正]。
J Physiol Biochem. 2012 Mar;68(1):129-39. doi: 10.1007/s13105-011-0126-y. Epub 2011 Nov 5.

引用本文的文献

1
Site-Specific Nanobody Inhibitors of the Proteasomal Deubiquitinase UCH37.蛋白酶体去泛素化酶UCH37的位点特异性纳米抗体抑制剂
bioRxiv. 2025 Aug 13:2025.08.11.669711. doi: 10.1101/2025.08.11.669711.
2
UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression.UCHL3:DNA损伤修复和肿瘤进展中的关键去泛素化酶。
Cancer Cell Int. 2025 Jul 21;25(1):276. doi: 10.1186/s12935-025-03884-x.
3
Mechanisms and regulation of substrate degradation by the 26S proteasome.26S蛋白酶体对底物降解的机制与调控
Nat Rev Mol Cell Biol. 2025 Feb;26(2):104-122. doi: 10.1038/s41580-024-00778-0. Epub 2024 Oct 3.
4
A structure-based designed small molecule depletes hRpn13 and a select group of KEN box proteins.基于结构设计的小分子耗尽 hRpn13 和一组选择的 KEN 盒蛋白。
Nat Commun. 2024 Mar 20;15(1):2485. doi: 10.1038/s41467-024-46644-7.
5
hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50.hRpn13 通过表观遗传因子 HDAC8、PADI4 和转录因子 NF-κB p50 塑造蛋白质组和转录组。
Mol Cell. 2024 Feb 1;84(3):522-537.e8. doi: 10.1016/j.molcel.2023.11.035. Epub 2023 Dec 26.
6
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.Up284 的开发及抗癌特性:一种新型的候选 ADAM13/RPN13 抑制剂。
PLoS One. 2023 Jun 14;18(6):e0285221. doi: 10.1371/journal.pone.0285221. eCollection 2023.
7
Proteasome substrate receptors and their therapeutic potential.蛋白酶体底物受体及其治疗潜力。
Trends Biochem Sci. 2022 Nov;47(11):950-964. doi: 10.1016/j.tibs.2022.06.006. Epub 2022 Jul 9.
8
Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma.结构导向的双功能分子针对多发性骨髓瘤中上调的缺乏 DEUBAD 的 hRpn13 物种发挥作用。
Nat Commun. 2021 Dec 16;12(1):7318. doi: 10.1038/s41467-021-27570-4.
9
Branched ubiquitin chain binding and deubiquitination by UCH37 facilitate proteasome clearance of stress-induced inclusions.分支泛素链结合和解泛素化作用由UCH37 介导,可促进蛋白酶体清除应激诱导的包涵体。
Elife. 2021 Nov 11;10:e72798. doi: 10.7554/eLife.72798.
10
Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.泛素羧基末端水解酶与人类恶性肿瘤:对头颈部癌的新预后及治疗意义
Front Oncol. 2021 Jan 29;10:592501. doi: 10.3389/fonc.2020.592501. eCollection 2020.

本文引用的文献

1
Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome.Rpn1为蛋白酶体提供相邻的底物结合和去泛素化受体位点。
Science. 2016 Feb 19;351(6275). doi: 10.1126/science.aad9421.
2
Ixazomib: First Global Approval.伊沙佐米:首次全球获批。
Drugs. 2016 Mar;76(3):405-11. doi: 10.1007/s40265-016-0548-5.
3
Gates, Channels, and Switches: Elements of the Proteasome Machine.门、通道与开关:蛋白酶体机器的组成要素
Trends Biochem Sci. 2016 Jan;41(1):77-93. doi: 10.1016/j.tibs.2015.10.009. Epub 2015 Nov 28.
4
A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells.一种高亲和力的源自hRpn2的肽,可在293T细胞中从蛋白酶体上取代人Rpn13。
PLoS One. 2015 Oct 14;10(10):e0140518. doi: 10.1371/journal.pone.0140518. eCollection 2015.
5
The 26S proteasome is a multifaceted target for anti-cancer therapies.26S蛋白酶体是抗癌疗法的一个多方面的靶点。
Oncotarget. 2015 Sep 22;6(28):24733-49. doi: 10.18632/oncotarget.4619.
6
A reversible and highly selective inhibitor of the proteasomal ubiquitin receptor rpn13 is toxic to multiple myeloma cells.蛋白酶体泛素受体rpn13的一种可逆且高度选择性抑制剂对多发性骨髓瘤细胞有毒性。
J Am Chem Soc. 2015 May 20;137(19):6312-9. doi: 10.1021/jacs.5b02069. Epub 2015 May 8.
7
Knockdown of Adhesion-Regulating Molecule 1 Inhibits Proliferation in HL60 Cells.粘附调节分子1的敲低抑制HL60细胞的增殖。
Acta Haematol. 2015;134(2):88-100. doi: 10.1159/000369916. Epub 2015 Apr 21.
8
Structural plasticity allows UCH37 to be primed by RPN13 or locked down by INO80G.结构可塑性使UCH37能够被RPN13启动或被INO80G锁定。
Mol Cell. 2015 Mar 5;57(5):767-768. doi: 10.1016/j.molcel.2015.02.025.
9
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.泛素羧基末端水解酶37(UCH37)去泛素化酶激活与抑制的结构基础
Mol Cell. 2015 Mar 5;57(5):901-911. doi: 10.1016/j.molcel.2015.01.016. Epub 2015 Feb 19.
10
Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13 and INO80G.RPN13和INO80G中DEUBAD结构域对UCH-L5的激活和抑制机制。
Mol Cell. 2015 Mar 5;57(5):887-900. doi: 10.1016/j.molcel.2014.12.039. Epub 2015 Feb 19.